We are live on ! Find out more
CCM

Context Capital Management Portfolio holdings

AUM $5.15B
1-Year Est. Return 1.28%
This Fund
S&P 500
This Quarter Est. Return
+0.16%
1 Year Est. Return
+1.28%
3 Year Est. Return
+3.38%
5 Year Est. Return
+13.56%
10 Year Est. Return
+42.39%
AUM
$1.11B
AUM Growth
-$84.7M
Cap. Flow
-$988M
Cap. Flow %
-89.31%
Top 10 Hldgs %
27.41%
Holding
368
New
21
Increased
1
Reduced
6
Closed
53
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDTCW
76
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$15K ﹤0.01%
127,872
FLDDW
77
Fold Holdings Warrant
FLDDW
$1.3M
$15K ﹤0.01%
250,000
BIOSW
78
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$15K ﹤0.01%
105,069
NOVVR
79
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$15K ﹤0.01%
87,700
PPYAW
80
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$14K ﹤0.01%
250,000
HHGCR
81
DELISTED
HHG Capital Corporation Rights
HHGCR
$14K ﹤0.01%
112,030
HOLOW icon
82
MicroCloud Hologram Inc Warrant
HOLOW
$13K ﹤0.01%
108,098
IVCAW
83
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$13K ﹤0.01%
212,035
BNIXW
84
DELISTED
Bannix Acquisition Corp. Warrant
BNIXW
$13K ﹤0.01%
320,484
FTIIW
85
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$13K ﹤0.01%
150,000
ZFOXW
86
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
$13K ﹤0.01%
457,295
CLINR
87
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$13K ﹤0.01%
+99,800
New +$16.7K
FGMCW
88
DELISTED
FG Merger Corp. Warrant
FGMCW
$13K ﹤0.01%
243,750
OPTXW icon
89
Syntec Optics Holdings Warrant
OPTXW
$15.5M
$12K ﹤0.01%
221,235
CEROW
90
DELISTED
CERo Therapeutics Warrants
CEROW
$12K ﹤0.01%
200,000
SPECW
91
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$12K ﹤0.01%
118,203
CNGLW
92
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
$12K ﹤0.01%
499,500
COOLW
93
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$12K ﹤0.01%
95,500
FXCOR
94
DELISTED
Financial Strategies Acquisition Corp. Rights
FXCOR
$12K ﹤0.01%
249,000
KACLR
95
DELISTED
Kairous Acquisition Corp. Limited Rights
KACLR
$11K ﹤0.01%
180,000
PHYT.WS
96
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$11K ﹤0.01%
111,700
ASCBW
97
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
$11K ﹤0.01%
700,000
TLGYW
98
DELISTED
TLGY Acquisition Corporation Warrant
TLGYW
$11K ﹤0.01%
75,000
BENFW icon
99
Beneficient Warrant
BENFW
$186K
$10K ﹤0.01%
+210,024
New +$14.1K
RENEW
100
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$10K ﹤0.01%
66,666

Similar funds

Context Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Context Capital Management held 368 positions worth $1.11B, down 7.1% from $1.19B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Context Capital Management withdrew a net $988M in Q2 2023, closing 53 positions and reducing 6 holdings. Its most notable exit was Bitcoin Depot, an estimated $8.78M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.7% of assets, down from 9.3% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Context Capital Management opened a new position in Aimfinity Investment Corp I Subunit worth $2.11M.

  • Context Capital Management's largest Q2 2023 buy was Aimfinity Investment Corp I Subunit: 200,000 shares worth $2.11M.
  • Context Capital Management added most to GCM Grosvenor Inc Warrant in Q2 2023, an estimated $5.46K increase.
  • Context Capital Management's biggest Q2 2023 reduction was ConnectM Technology Solutions, Inc. Common Stock, cutting an estimated $5.17M.
  • Context Capital Management fully exited Bitcoin Depot in Q2 2023, selling an estimated $8.78M.
  • Context Capital Management's ten largest holdings make up 27% of its $1.11B portfolio in Q2 2023.
  • Context Capital Management opened 21 new positions and closed 53 in Q2 2023.
  • Context Capital Management's portfolio value fell 7.1% quarter-over-quarter to $1.11B.

Based on Context Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.